Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-6-4
pubmed:abstractText
Basal forebrain (BF) cholinergic regulation of cataplexy was investigated in narcoleptic canines. Specific cholinergic agonists and antagonists, and excitatory or inhibitory amino acid neurotransmitter receptor agonists, were perfused through microdialysis probes implanted bilaterally in the BF of narcoleptic canines. Cataplexy was monitored using the food-elicited cataplexy test (FECT) and recordings of electroencephalogram, electrooculogram, and electromyogram. In narcoleptic canines, carbachol and oxotremorine (10(-5)-10(-3) M), but not McN-A-343 or nicotine (10(-4)-10(-3) M), produced a dose-dependent increase in cataplexy. In addition, N-methyl-d-aspartate (10(-4)-10(-3) M) and kainic acid (10(-5)-10(-4) M) did not have any effects, while muscimol (10(-3) M) produced a weak (P < 0.10) increase in cataplexy. In control canines, carbachol (10(-5)-10(-3) M), but not oxotremorine (10(-4)-10(-3) M), produced muscle atonia after the highest concentration in one of three animals. Carbachol (10(-3) M)-induced cataplexy in narcoleptic canines was blocked by equimolar perfusion with the muscarinic antagonists atropine, gallamine, and 4-DAMP but not pirenzepine. These findings indicate that carbachol-stimulated cataplexy in the BF of narcoleptic canines is mediated by M2, and perhaps M3, muscarinic receptors. The release of acetylcholine in the BF was also examined during FECT and non-FECT behavioral stimulation in narcoleptic and control canines. A significant increase in acetylcholine release was found in both narcoleptic and control BF during FECT stimulation. In contrast, simple motor activity and feeding, approximating that which occurs during an FECT, did not affect acetylcholine release in the BF of narcoleptic canines. These findings indicate that BF acetylcholine release is enhanced during learned emotion/reward associated behaviors in canines.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/(4-(m-Chlorophenylcarbamoyloxy)-2-bu..., http://linkedlifedata.com/resource/pubmed/chemical/4-diphenylacetoxy-1,1-dimethylpiperi..., http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine, http://linkedlifedata.com/resource/pubmed/chemical/Atropine, http://linkedlifedata.com/resource/pubmed/chemical/Carbachol, http://linkedlifedata.com/resource/pubmed/chemical/GABA Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Gallamine Triethiodide, http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Muscimol, http://linkedlifedata.com/resource/pubmed/chemical/Nicotine, http://linkedlifedata.com/resource/pubmed/chemical/Nicotinic Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Nicotinic Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Oxotremorine, http://linkedlifedata.com/resource/pubmed/chemical/Piperidines, http://linkedlifedata.com/resource/pubmed/chemical/Pirenzepine
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0014-4886
pubmed:author
pubmed:copyrightInfo
Copyright 1998 Academic Press.
pubmed:issnType
Print
pubmed:volume
151
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
89-104
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9582257-(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium..., pubmed-meshheading:9582257-Acetylcholine, pubmed-meshheading:9582257-Animals, pubmed-meshheading:9582257-Atropine, pubmed-meshheading:9582257-Behavior, Animal, pubmed-meshheading:9582257-Carbachol, pubmed-meshheading:9582257-Cataplexy, pubmed-meshheading:9582257-Cholinergic Fibers, pubmed-meshheading:9582257-Dogs, pubmed-meshheading:9582257-Feeding Behavior, pubmed-meshheading:9582257-Female, pubmed-meshheading:9582257-GABA Agonists, pubmed-meshheading:9582257-Gallamine Triethiodide, pubmed-meshheading:9582257-Male, pubmed-meshheading:9582257-Microdialysis, pubmed-meshheading:9582257-Muscarinic Agonists, pubmed-meshheading:9582257-Muscarinic Antagonists, pubmed-meshheading:9582257-Muscimol, pubmed-meshheading:9582257-Nicotine, pubmed-meshheading:9582257-Nicotinic Agonists, pubmed-meshheading:9582257-Nicotinic Antagonists, pubmed-meshheading:9582257-Oxotremorine, pubmed-meshheading:9582257-Piperidines, pubmed-meshheading:9582257-Pirenzepine, pubmed-meshheading:9582257-Prosencephalon
pubmed:year
1998
pubmed:articleTitle
Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines.
pubmed:affiliation
Center for Narcolepsy Research, Department of Psychiatry and Behavioral Sciences, Stanford University, 1201 Welch Road/MSLS Building, Palo Alto, California, 94304-5485, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.